PTGS2 and breast cancer: We found that miR-101-3p expression is lost in brain metastatic breast cancer cells, while ectopic expression of miR-101-3p reduces transmigration of cancer cells through the brain endothelium through reduction of COX-2/MMP1 expression which interferes with the inter-endothelial junctions.